Current Understanding of Post-COVID Pulmonary Fibrosis: Where Are We?

Bridi, Guilherme das Posses; Tanni, Suzana Erico; Baldi, Bruno Guedes.
Arch. bronconeumol. (Ed. impr.) ; 59(2): 69-70, feb. 2023. ilus
Artículo en Inglés | IBECS (España) | ID: ibc-215575

Documentos relacionados

  1. "A Chain Only as Strong as Its Weakest Link": An Up-to-Date Literature Review on the Bidirectional Interaction of Pulmonary Fibrosis and COVID-19.
  2. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis.
  3. Diabetes Mellitus, Hypertension, and Death among 32 Patients with MERS-CoV Infection, Saudi Arabia.
  4. COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead.
  5. COVID-19: Epidemiology, Pathophysiology, Transmission, Symptoms.
  6. Are there pulmonary sequelae in patients recovering from COVID-19?
  7. Coinfection with PEDV and BVDV induces inflammatory bowel disease pathway highly enriched in PK-15 cells.
  8. Encapsulation: Governing actual uncertainty in the coronavirus pandemic.
  9. Monitoring real-time junior doctor sentiment from comments on a public social media platform: a retrospective observational study.
  10. The Spanish 1918 Flu and the COVID-19 Disease: The Art of Remembering and Foreshadowing Pandemics.